Bionexus Gene Lab Corporation

BGLC·NASDAQ·$2.07Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/26 10-QQ1 ended 03/31/2605/15/26 10-KFY 202504/14/26 10-QQ3 ended 09/30/2511/14/25 10-QQ2 ended 06/30/2508/18/25

Disclosures

8-KCurrent report10/07/26 8-KCurrent report07/28/26 8-KCurrent report06/05/26 8-KCurrent report03/17/26 8-KCurrent report02/23/26

Prospectuses and Registrations

S-3Shelf registration11/07/25 424B4Prospectus07/21/23 S-1/ARegistration statement (amended)07/17/23 S-1/ARegistration statement (amended)07/05/23 S-1/ARegistration statement (amended)05/09/23

Proxies

DEF 14ADefinitive proxy12/03/25 PRE 14APreliminary proxy11/14/25 DEFR14ADefinitive proxy (revised)02/28/25 DEF 14ADefinitive proxy02/27/25 PRE 14APreliminary proxy02/10/25

Ownership

SC 13GBeneficial ownership10/22/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26 Form 4Insider transaction08/14/26

Other

NT 10-KLate filing notification (10-K)03/31/26 NT 10-QLate filing notification (10-Q)08/14/25 NT 10-KLate filing notification (10-K)03/31/25 NT 10-QLate filing notification (10-Q)11/14/24 UPLOADLetter from the SEC06/06/24